0001237899-13-000034.txt : 20130514 0001237899-13-000034.hdr.sgml : 20130514 20130514115149 ACCESSION NUMBER: 0001237899-13-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130510 FILED AS OF DATE: 20130514 DATE AS OF CHANGE: 20130514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13840112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-05-10 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Research and Development S Common Stock 2013-05-10 4 M 0 55438.0 21.92 A 104426 D Common Stock 2013-05-10 4 F 0 4527.0 268.4 D 99899 D Common Stock 2013-05-10 4 F 0 27873.0 268.4 D 72026 D Common Stock 2013-05-13 4 S 0 13378.0 276.71 D 58648 D Common Stock 2013-05-13 4 S 0 9660.0 277.12 D 48988 D Common Stock 5536 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 21.92 2013-05-10 4 M 0 55438.0 D 2017-12-17 Common Stock 55438 0 D Non-Qualified Stock Option (right to buy) 268.4 2013-05-10 4 A 0 4527.0 A 2013-11-10 2023-05-10 Common Stock 4527 4527 D Represents volume-weighted average price of sales of 13,378 shares of Company stock on May 13, 2013 at prices ranging from $276.00 to $276.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 13, 2013 at each separate price. Represents volume-weighted average price of sales of 9,660 shares of Company stock on May 13, 2013 at prices ranging from $277.00 to $277.9. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 13, 2013 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. .s.**Neil Stahl 2013-05-14